Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Cosmo, EFG International, Sika, Swissquote: Swiss Equity Preview

Don't Miss Out —
Follow us on:

July 30 (Bloomberg) -- The following companies’ shares may be active in Zurich. Stock symbols are in parentheses after company names. Prices are from the last close.

The Swiss Market Index of the biggest and most actively traded companies lost 0.9 percent to 6,220.65. The broader Swiss Performance Index fell 0.8 percent to 5,506.79.

Cosmo Pharmaceuticals SpA (COPN SW): The Italian developer of treatments for digestive-tract infections said first-half revenue rose to 14.3 million euros ($18.7 million) while operating profit advanced to 2.1 million euros. The shares were unchanged at 16 Swiss francs.

EFG International AG (EFGN SW): The Swiss bank had its long-term issuer rating lowered to A3 from A2 by Moody’s Investors Service. The shares tumbled 6.8 percent to 11.7 francs.

Sika AG (SIK SW): Europe’s biggest maker of chemicals used in construction said first-half net income rose 63 percent to 150.5 million francs ($144.5 million). The shares rose 2 percent to 1,963 francs.

Swissquote Group Holding AG (SQN SW): Switzerland’s largest online broker said first-half net profit fell to 13.7 million francs from 15.9 million francs a year earlier because of higher costs. The company said it’s sticking to its full-year growth targets. The shares rose 0.5 percent to 44 francs.

To contact the reporter on this story: Adam Ewing in Stockholm at aewing5@bloomberg.net.

To contact the editor responsible for this story: David Merritt at dmerritt1@bloomberg.net.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.